Stocks / NASDAQ / Cognition Therapeutics Inc.

Cognition Therapeutics Inc.

Our Opinion

Cognition Therapeutics Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

“If this research is successful, CogRx will be able to optimize an initial drug candidate to improve effectiveness at stopping the toxicity and will then test these in validated animal models.” Read the following article

Company Description

Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina.

Company Website: